Top

Reactions Weekly

Published in:

01-03-2024 | Urosepticemia | Case report

Cyclophosphamide/prednisolone

Severe acute respiratory syndrome coronavirus-2 infection, septic arthritis and extended spectrum beta-lactamase Klebsiella-urosepsis

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Gradim M, et al. Acquired Hemophilia A in Very Old Patients: Issues on Therapy Choice. A Case Report. Research and Practice in Thrombosis and Haemostasis 7 (Suppl. 2): abstr. PB1235, Oct 2023. Available from: URL: https://dx.doi.org/10.1016/j.rpth.2023.101046 [abstract]

Title: Cyclophosphamide/prednisolone
Severe acute respiratory syndrome coronavirus-2 infection, septic arthritis and extended spectrum beta-lactamase Klebsiella-urosepsis
Publication date: 01-03-2024
Publisher: Springer International Publishing
Keywords: Urosepticemia
Pyarthrosis
Prednisolone
SARS-CoV-2
Severe Acute Respiratory Syndrome Coronavirus
Hemophilia
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-54444-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cyclophosphamide/prednisolone

Severe acute respiratory syndrome coronavirus-2 infection, septic arthritis and extended spectrum beta-lactamase Klebsiella-urosepsis

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Bisoprolol

Mitomycin

Tozinameran

Triamcinolone

Paclitaxel

Multiple drugs